phone icon  Int'l : +1 (503) 505-6949
0
Shopping Cart is Empty..
$ 0

Global In Vitro Fertilization (IVF) Market (Instruments, Reagents and Media, Technology, Geography) - Size, Share, Trends, Opportunities, Global Demand, Insights, Analysis, Research, Report, Company Profiles, Segmentation and Forecast, 2013 - 2020

 Pages:106
pubn Published: Jan 2014
tab_nTables: 50
aut_nAuthor(s): Debbie Shields and Rohini Patil
 p_n

In-vitro fertilization is a type of assisted reproductive technology that helps women in conceiving. The global IVF market was valued at $9.3 billion in 2012 and is expected to grow up to $21.6 billion by 2020. Delayed pregnancy in women is one of the major driving factors of the IVF market, as the chances of conceiving lowers with age. The pregnancy success rate with IVF technique is higher in the age group of 35-39.  Other driving factors of the IVF market are rise in infertility rate due to rise in stress levels, change in life style and fertility related diseases. Globally, the number of couples with infertility issues was found to be 48.5 million in 2010.

The major limiting factor of this market is the cost involved in the treatment. The patient may not conceive in the first cycle of IVF procedure. Many cycles have to be undergone by the patient to achieve pregnancy, and this adds to the overall cost. The average cost of this procedure is approximately $10,000-$20,000. This acts as a major limitation in adoption of the technique for people with low income. Another challenge is the low level of awareness in the developing economies such as Nigeria. Awareness can be created through medical tourism and availability of low cost IVF treatments.

The companies profiled in this report include Vitrolife AB, Cooper Surgical. Inc., Cook Medicals, Thermo Scientific, Irvine Scientific Inc., Genea Biomedx, Oxford Gene Technology, Auxogyn Inc., EMD Serono Inc. and Ova Science.

Infertile Couples and Investors, both can capitalized form Global IVF market

KEY BENEFITS

  • In-depth analysis of the IVF market, segmented based on instruments, reagents and media, technology, end users and geographies
  • Quantitative analysis of the current market and estimations through 2013-2020   
  • Assessment and ranking of the factors affecting the global market and impact analysis of the same  
  • Identification of key investment pockets in the market, which would assist companies to take profitable investment decisions
  • Study of the bargaining power of buyers and suppliers in the market, based on porter’s five force analysis
  • Understanding the key intermediaries in the market based on value chain analysis
  • Analysis of trends in various geographic segments that would help the companies to plan their strategies depending on the region
  • SWOT and competitive analysis of the key players, which would help stakeholders to understand trends followed by their competitors and take actionable decisions

KEY AUDIENCES

  • Hospitals
  • Fertility clinics
  • Instruments and reagent manufacturers
  • Cryopreservation banks
  • Government and private institutes

CHAPTER 1 INTRODUCTION

1.1 Key Benefits
1.2 Key Audiences
1.3 Research Methodology

1.3.1 Secondary research
1.3.2 Primary research
1.3.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

CHAPTER 3 GLOBAL IVF MARKET OVERVIEW

3.1 Market definition and scope
3.2 Alternative technologies

3.2.1 IUI technique

3.2.1.1 Factors assessed for the procedure
3.2.1.2 Reasons for use of the technique
3.2.1.3 Benefits of this technique
3.2.1.4 Risks

3.2.2 Difference between IUI and IVF technique
3.2.3 GIFT technique

3.2.3.1 Difference between GIFT and IVF technique

3.2.4 ZIFT technique

3.2.4.1 Differences between ZIFT and IVF technique

3.3 Replacing IVF procedures by fertility drugs and surgeries

3.3.1 Female infertility treatments

3.3.1.1 Limitations of fertility drugs

3.3.2 Male infertility treatments

3.4 Costs related to IVF procedures
3.5 Role of donors in the IVF market

3.5.1 Egg donation

3.5.1.1 Egg sharing

3.5.2 Sperm donation
3.5.3 Embryo donation
3.5.4 Donation for research

3.6 Surrogacy

3.6.1 Legal issues

3.7 Rise in same sex couples

3.7.1 Artificial insemination
3.7.2 Surrogate mothers
3.7.3 In-vitro fertilization

3.8 Advanced technologies in IVF

3.8.1 Capsule IVF
3.8.2 Three parent IVF

3.8.2.1 Ethical concerns

3.8.3 Mini IVF

3.8.3.1 Advantages
3.8.3.2 Drawbacks

3.8.4 EmbryoScope

3.8.4.1 Advantages

3.8.5 PICSI

3.9 Fertility treatment and Gender selection

3.9.1 Methods of sex selection

3.9.1.1 Gradient method
3.9.1.2 Flow cytometry technique
3.9.1.3 Pre-implantation genetic diagnosis (PGD)
3.9.1.4 Ethical and legal issues

3.10 Metabolomics in embryo screening methods

3.11 Application of stem cells in IVF
3.12 IVF and resource poor countries
3.13 Top ten factors impacting IVF market
3.14 Top winning strategies in the IVF market
3.15 Porter's five forces analysis

3.15.1 Competition declining suppliers power
3.15.2 Availability of options impacting buyer power
3.15.3 High cost -a hindrance to new entrants
3.15.4 Application of strategies to overcome competition
3.15.5 Inefficient threat from substitutes

3.16 Value chain analysis
3.17 Insurance reimbursement Scenario
3.18 Regulatory issues and legislations
3.19 Clinical trials

3.19.1 Trial 1: To study the DHEA outcomes on poor responders of IVF
3.19.2 Trial 2: Use of Metformin in IVF treatment of polycystic ovary syndrome
3.19.3 Trial 3- Treatment of first line unexplained infertility by IVF and IUI in controlled ovarian stimulation
3.19.4 Trial 4: Fast track to IVF (FASTT) Vs conventional infertility treatment
3.19.5 Trial 5: To study the evaluation of multiple doses of NT100 in women with repeated IVF failures

3.20 Market dynamics

3.20.1 Drivers

3.20.1.1 Age
3.20.1.2 Rise in infertility rates
3.20.1.3 Advancement in technology
3.20.1.4 Rise in donation
3.20.1.5 Increase in average income
3.20.1.6 Increase in success rates

3.20.2 Restraints

3.20.2.1 Physical and emotional impact
3.20.2.2 Ethical and legal issues
3.20.2.3 Cost of the treatment
3.20.2.4 Multiple pregnancies
3.20.2.5 Low awareness level

3.20.3 Opportunities:

3.20.3.1 Medical tourism
3.20.3.2 New technology trends
3.20.3.3 Rise in same sex marriages

CHAPTER 4 GLOBAL IVF MARKET BY INSTRUMENTS

4.1 Global IVF market by instruments types, 2012-2020,$million
4.2 Global IVF instruments market, by geography, 2012-2020 ($Million)
4.3 Incubators

4.3.1 Global IVF incubators market , by geography, 2012-2020 ($Million)

4.4 Cryosystem

4.4.1 Global IVF cryosystem market, by geography, 2012-2020 ($Million)

4.5 Imaging system

4.5.1 Global IVF Imaging system market , by geography, 2012-2020 ($Million)

4.6 Cabinet( work station)

4.6.1 Global IVF cabinets market , by geography, 2012-2020 ($Million)

4.7 Ovum Aspiration pump

4.7.1 Global IVF ovum aspiration pump market , by geography, 2012-2020 ($Million)

4.8 Sperm separation system

4.8.1 Global IVF Sperm seperation system market, by geography, 2012-2020 ($Million)

4.9 Accessories and disposables

4.9.1 Semen analysis chamber
4.9.2 Plastic ware
4.9.3 Oocyte retrieval needles
4.9.4 Miscellaneous disposables
4.9.5 Global IVF accessories and disposable market , by geography, 2012-2020 ($Million)

4.10 Micro Manipulator System

4.10.1 Global IVF Micromanipulator market , by geography, 2012-2020 ($Million)

4.11 Others

4.11.1 Refrigerators

4.11.1.1 Global IVF other instruments market , by geography, 2012-2020 ($Million)

CHAPTER 5 GLOBAL IVF MARKET BY REAGENTS AND MEDIA

5.1 Global IVF market by reagents and media types,2012-2020,$million
5.2 Global IVF reagents and media market, by geography, 2012-2020 ($Million)
5.3 Cryopreservation media

5.3.1 Embryo cryopreservation media
5.3.2 Sperm cryopreservation media
5.3.3 Oocyte cryopreservation media

5.3.3.1 Disadvantage
5.3.3.2 Advantages

5.3.4 Global IVF cryopreservation media market , by geography, 2012-2020 ($Million)

5.4 Semen processing media

5.4.1 Global IVF semen processing media market , by geography, 2012-2020 ($Million)

5.5 Ovum processing media

5.5.1 Global IVF ovum processing media market , by geography, 2012-2020 ($Million)

5.6 Embryo culture media

5.6.1 Global IVF embryo culture media market , by geography, 2012-2020 ($Million)

CHAPTER 6 GLOBAL IVF MARKET BY TECHNOLOGY

6.1 Global IVF market, by technology, 2012-2020 ($Million)
6.2 Global IVF technology market, by geography, 2012-2020 ($Million)
6.3 PGD technique

6.3.1 Drivers
6.3.2 Restraints
6.3.3 Global IVF pre-implantation genetic diagnosis market , by geography, 2012-2020 ($Million)

6.4 FER technique

6.4.1 Reasons to use this technique
6.4.2 Advantages of FER technique
6.4.3 Disadvantages of FER technique

6.4.4 Global IVF Frozen embryo replacement market , by geography, 2012-2020 ($Million)

6.5 ICSI Technique

6.5.1 Benefits
6.5.2 Risks
6.5.3 Global IVF intra cytoplasmic sperm injection market , by geography, 2012-2020 ($Million)

6.6 Others:

6.6.1 Global IVF other technology market , by geography, 2012-2020 ($Million)
6.6.2 IVM Technique
6.6.3 Assisted hatching

CHAPTER 7 GLOBAL IVF MARKET BY END USERS

7.1 Global IVF market by end users, 2012-2020 ($Million)
7.2 Global IVF end use market, by geography, 2012-2020 ($Million)
7.3 Hospitals

7.3.1 Global IVF Hospitals market , by geography, 2012-2020 ($Million)

7.4 Clinics

7.4.1 Global IVF Clinics market , by geography, 2012-2020 ($Million)

7.5 Surgical centers

7.5.1 Global IVF Surgical centers market , by geography, 2012-2020 ($Million)

7.6 Clinical research institutes

7.6.1 Global IVF clinical research institutes market , by geography, 2012-2020 ($Million)

7.7 Banks

7.7.1 Global IVF banks market , by geography, 2012-2020 ($Million)

CHAPTER 8 IVF MARKET BY GEOGRAPHY

8.1 Europe
8.2 North America

8.2.1 North American IVF market, 2012-2020 ($Million)

8.3 Asia pacific

8.3.1 Asia Pacific IVF market, 2012-2020 ($Million)

8.4 RoW

8.4.1 RoW IVF market, 2012-2020 ($Million)

CHAPTER 9 COMPANY PROFILES

9.1 Vitrolife AB

9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Business performance
9.1.4 Strategic moves and developments

9.1.4.1 Primary strategies: regulatory approvals, acquisition and agreements
9.1.4.2 Others

9.1.5 SWOT Analysis of Vitrolife AB

9.2 EMD Serono, Inc

9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Business performance
9.2.4 Strategic moves and developments

9.2.4.1 Primary strategies

9.2.5 SWOT Analysis of EMD Serono, Inc

9.3 Irvine scientific

9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Business performance
9.3.4 Strategic moves and developments

9.3.4.1 Primary strategy: FDA approvals

9.3.5 SWOT Analysis of Irvine scientific

9.4 Cooper Surgical, Inc.

9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Business performance
9.4.4 Strategic moves and developments

9.4.4.1 Primary strategies

9.4.5 SWOT Analysis of Cooper Surgical, Inc

9.5 Cook Medical, Inc

9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Strategic moves and developments

9.5.3.1 Primary strategies

9.5.4 SWOT Analysis of Cook medical

9.6 Thermo Fisher Scientific Inc.

9.6.1 Company overview:
9.6.2 Company snapshot
9.6.3 Business Performance
9.6.4 Strategic moves and developments

9.6.4.1 Primary strategy: product launch

9.6.5 SWOT Analysis of Thermo Fisher Scientific Inc.

9.7 Genea Biomedx

9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Strategic moves and developments

9.7.3.1 Primary strategy: product launch

9.7.4 SWOT Analysis of Genea Biomedx

9.8 Auxogyn, Inc

9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Strategic moves and developments

9.8.3.1 Primary strategies- Agreement and partnership
9.8.3.2 Others strategies

9.8.4 SWOT Analysis of Auxogyn, Inc

9.9 Oxford Gene Technology

9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Strategic moves and developments

9.9.3.1 Primary strategy: product launch

9.9.4 SWOT analysis of oxford gene technology

9.10 Ovascience

9.10.1 Company overview
9.10.2 Business Performance
9.10.3 Strategic moves and developments

9.10.3.1 Primary strategy

9.10.4 SWOT analysis of Ovascience

LIST OF TABLES:

TABLE 1 GLOBAL IVF INSTRUMENTS MARKET, BY GEOGRAPHY, 2012-2020 ($MILLION)
TABLE 2 INSURANCE COVERAGE FOR COUNTRIES
TABLE 3 GLOBAL IVF MARKET BY INSTRUMENTS TYPES,2012-2020 ($MILLION)
TABLE 4 GLOBAL IVF INSTRUMENTS MARKET, BY GEOGRAPHY, 2012-2020 ($MILLION)
TABLE 5 GLOBAL IVF INCUBATORS MARKET , BY GEOGRAPHY, 2012-2020 ($MILLION)
TABLE 6 GLOBAL IVF CRYOSYSTEM MARKET , BY GEOGRAPHY, 2012-2020 ($MILLION)
TABLE 7 GLOBAL IVF IMAGING SYSTEM MARKET , BY GEOGRAPHY, 2012-2020 ($MILLION)
TABLE 8 GLOBAL IVF CABINETS MARKET , BY GEOGRAPHY, 2012-2020 ($MILLION)
TABLE 9 GLOBAL IVF OVUM APIRATION PUMP MARKET , BY GEOGRAPHY, 2012-2020 ($MILLION)
TABLE 10 GLOBAL IVF SPERM SEPERATION SYSTEM MARKET, BY GEOGRAPHY, 2012-2020 ($MILLION)
TABLE 11 GLOBAL IVF ACCESSORIES AND DISPOSABLE MARKET , BY GEOGRAPHY, 2012-2020 ($MILLION)
TABLE 12 GLOBAL IVF MICROMANIPULATOR MARKET , BY GEOGRAPHY, 2012-2020 ($MILLION)
TABLE 13 GLOBAL IVF OTHER INSTRUMENTS MARKET , BY GEOGRAPHY, 2012-2020 ($MILLION)
TABLE 14 GLOBAL IVF MARKET BY REAGENTS AND MEDIA TYPES,2012-2020,$MILLION
TABLE 15 GLOBAL IVF REAGENTS AND MEDIA MARKET, BY GEOGRAPHY, 2012-2020 ($MILLION)
TABLE 16 CRYOPRESERVATION MEDIA BY VARIOUS COMPANIES
TABLE 17 GLOBAL IVF CRYOPRESERVATION MEDIA MARKET , BY GEOGRAPHY, 2012-2020 ($MILLION)
TABLE 18 GLOBAL IVF SEMEN PROCESSING MEDIA MARKET , BY GEOGRAPHY, 2012-2020 ($MILLION)
TABLE 19 GLOBAL IVF OVUM PROCESSING MEDIA MARKET , BY GEOGRAPHY, 2012-2020 ($MILLION)
TABLE 20 EMBRYO CULTURE MEDIA BY VARIOUS COMPANIES
TABLE 22 GLOBAL IVF EMBRYO CULTURE MEDIA MARKET , BY GEOGRAPHY, 2012-2020 ($MILLION)
TABLE 23 GLOBAL IVF MARKET, BY TECHNOLOGY, 2012-2020 ($MILLION)
TABLE 24 GLOBAL IVF TECHNOLOGY MARKET, BY GEOGRAPHY, 2012-2020 ($MILLION)
TABLE 25 GLOBAL IVF PRE-IMPLANTATION GENETIC DIAGNOSIS MARKET , BY GEOGRAPHY, 2012-2020 ($MILLION)
TABLE 26 GLOBAL IVF FROZEN EMBRYO REPLACEMENT MARKET , BY GEOGRAPHY, 2012-2020 ($MILLION)
TABLE 27 GLOBAL IVF INTRA CYTOPLASMIC SPERM INJECTION MARKET , BY GEOGRAPHY, 2012-2020 ($MILLION)
TABLE 28 GLOBAL IVF OTHER TECHNOLOGY MARKET , BY GEOGRAPHY, 2012-2020 ($MILLION)
TABLE 29 GLOBAL IVF MARKET BY END USERS,2012-2020,$MILLION
TABLE 30 GLOBAL IVF END USER MARKET, BY GEOGRAPHY, 2012-2020 ($MILLION)
TABLE 31 GLOBAL IVF HOSPITALS MARKET , BY GEOGRAPHY, 2012-2020 ($MILLION)
TABLE 32 GLOBAL IVF CLINICS MARKET , BY GEOGRAPHY, 2012-2020 ($MILLION)
TABLE 33 GLOBAL IVF SURGICAL CENTERS MARKET , BY GEOGRAPHY, 2012-2020 ($MILLION)
TABLE 34 GLOBAL IVF CLINICAL RESEARCH INSTITUTES MARKET , BY GEOGRAPHY, 2012-2020 ($MILLION)
TABLE 35 GLOBAL IVF BANKS MARKET , BY GEOGRAPHY, 2012-2020 ($MILLION)
TABLE 36 EUROPE'S ACTIVE COUNTRIES FOR IVF TREATMENT, 2010
TABLE 37 EMEA IVF MARKET, 2012-2020 ($MILLION)
TABLE 38 NORTH AMERICAN IVF MARKET, 2012-2020 ($MILLION)
TABLE 39 ASIA PACIFIC IVF MARKET, 2012-2020 ($MILLION)
TABLE 40 ROW IVF MARKET, 2012-2020 ($Million)
TABLE 41 SNAP SHOT OF VITROLIFE AB
TABLE 42 SNAP SHOT OF EMD SERONO, INC
TABLE 43 SNAP SHOT OF IRVINE SCIENTIFIC
TABLE 44 SNAP SHOT OF COOPER SURGICAL, INC
TABLE 45 SNAP SHOT OF COOK MEDICAL
TABLE 46 SNAP SHOT OF THERMO FISHER SCIENTIFIC INC
TABLE 47 SNAP SHOT OF GENEA BIOMEDX
TABLE 48 SNAP SHOT OF AUXOGYN, INC
TABLE 49 SNAP SHOT OF OXFORD GENE TECHNOLOGY
TABLE 50 SNAP SHOT OF OVASCIENCE

LIST OF FIGURES:

FIG. 1 IUI SUCCESS RATES BY AGE UK, 2010
FIG. 2 HIGH ORDER BIRTH RATES: MEDICALLY ASSISTED VS IVF TECHNIQUE
FIG. 3 COST OF BASIC IVF TYPE PROCEDURES
FIG. 4 PERCENTAGE OF LIVE BIRTH USING DONOR EGGS, U.S.A, 2011
FIG. 5 LIVE BIRTH RATE PER CYCLE USING DONOR SPERM, U.K. 2010
FIG. 6 EMBRYOS CREATED USING DONOR EGGS, EUROPE
FIG. 7 ADOPTION RATE BY TYPE OF SURROGACY
FIG. 8 TOP FACTORS IMPACTING IVF MARKET (2013-2020)
FIG. 9 TOP WINNING STRATEGIES OF IVF MARKET (2010-2013)
FIG. 10 PORTERS FIVE FORCE ANALYSIS:
FIG. 11 VALUE CHAIN ANALYSIS OF GLOBAL IVF MARKET
FIG. 12 EFFECT OF AGE ON FERTILITY
FIG. 13 COMPARISON OF THE MEDIAS USED IN EMBRYO CULTURE
FIG. 14 SUCCESS RATE OF IVF TECHNIQUES PERFORMED BY AGE ,2011,U.S.A
FIG. 15 PREGNANCY RATE, PER FROZEN EMBRYO TRANSFER, 2011 (USA)
FIG. 16 LIVE BIRTH RATE PER CYCLE, AFTER FROZEN EMBRYO TRANSFER, 2011(USA)
FIG. 17 PERCENTAGES OF COUPLES SEEKING ICSI TREATMENT, BY THE REASON THEY SOUGHT TREATMENT, U.S.A ,2011
FIG. 18 PERCENTAGE OF CYCLES RESULTING IN LIVE BIRTHS (2010) U.K
FIG. 19 POLICIES PROVIDED BY ASIAN COUNTRIES TO SUPPORT ART TREATMENT
FIG. 20 SALES PER REGION 2012
FIG. 21 SWOT ANALYSIS OF VITROLIFE AB
FIG. 22 SALES BY REGION, 2012
FIG. 23 SWOT ANALYSIS OF EMD SERONO, INC
FIG. 24 SWOT ANALYSIS OF IRVINE SCIENTIFIC
FIG. 25 SWOT ANALYSIS OF COOPER SURGICAL, INC
FIG. 26 SWOT ANALYSIS OF COOK MEDICAL
FIG. 27 FINANCIAL REVENUES BY BUSINESS UNITS (2012)
FIG. 28 FINANCIAL REVENUES BY GEOGRAPHIC AREAS (2012)
FIG. 29 SWOT ANALYSIS OF THERMO FISHER SCIENTIFIC INC.
FIG. 30 SWOT ANALYSIS OF GENEA BIOMEDX
FIG. 31 SWOT ANALYSIS OF AUXOGYN, INC
FIG. 32 SWOT ANALYSIS OF OXFORD GENE TECHNOLOGY
FIG. 33 SWOT ANALYSIS OF OVASCIENCE

The IVF market analyzed in this report includes the various technologies of in-vitro fertilization along with the instruments, reagents and media used during the procedures. The market is segmented into instruments, reagents and media, technology and end users. This report excludes the in depth analysis of IVF in the service market and drugs market.

The scope of the market in the upcoming years is increase in technological advancement, high success rates, cost efficient treatments, and uncomplicated procedures that would save both the patients as well as the doctor’s time.

This market has growth opportunities in the geographic areas such as Asia pacific and RoW, where the rate of infertility is increasing and need for better IVF techniques that are cost efficient.

This market research report is an effort to provide the clear picture of the state of the market and sub markets over the next seven years. The report provides micro level analysis of the factors affecting the market, key market trends and industry drives and challenges for the better understanding of the market structure. The presentation of the market dynamics, competitive scenario and developments will enable marketers to aptly design their growth strategies and have competitive edge. Moreover, assessment of the top investment pockets and winning strategies will help in channelizing their investments in the right directions to garner better proceeds.

icon_01
SINGLE
USER
icon_02
GROUP LICENSE
Icon_03
SITE
LICENSE
Icon_04
GLOBAL LICENSE
$4515
$5325
$7350
$10680
SUPPORT
Delivery Formats
20% Free customization (Pre-sale)
16 Analyst hour support (Post Sale)
40 Analyst hour support (Post Sale)
160 hours of mini-consult
Free quarterly industry update
Free report on update (within 180 days)
MULTIPLE PURCHASE
Complimentary report with 2 reports
Complimentary report with 3 reports
Subscription Model
Have questions ?
connect
Need to add more ?
request
Get This Report
buy now
First time buyer ?
Check offers and discount
on this report
GET DISCOUNT
Need More Information
phone_n +1 (503) 505-6949

Help AMR help@alliedmarketresearch.com
Or
Send Enquiry
WHY ALLIED MARKET RESEARCH?
Infallible Methodology
To ensure high level data integrity, accurate analysis and impeccable forecasts
ANALYST SUPPORT
For complete satisfaction
CUSTOMIZATION
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET
Targeted market view to eliminate redundant information to provide valued information and save time of the reader
RECENTLY VIEWED PRODUCTS
get_n
SIMILAR MARKET REPORTS
  • ...
    In vitro diagnostics (IVD) is the technique of diagnostic test outside the human body in an artificial environment. The IVD market revenue is expected to reach $74.65 billion by 2020, from the market value of $53.32 billion in 2013, at a CAGR of 5.34% during 2014-2020. The global IVD market is segmented based on techniques, product type, usability, application, end user and geography (North America, Europe, Asia Pacific and Rest of World). Geographically, Asia Pacific is the fastest growing region and very opportune market that would generate highest revenue by 2020. Increase in the number of chronic and infectious diseases, and technological advancements are the major driving factors for the market.
    Jun 2014 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
  • ...
    Bio-implants have emerged as a promising solution for the variety of conditions such as cardiovascular, dental, orthopedic, ophthalmology, neurological disorders and others. Global market is forecast to reach $115.8 billion by 2020, registering a CAGR of 10.3% from 2014 to 2020.
    Oct 2014 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
  • ...
    Surgical equipment are medical devices/tools that serve the specific purpose during surgery. These tools enable the physical modification of biological tissue to provide access to underlying body components. The global surgical equipment market is expected to grow at significant CAGR of 11.1% during the forecast period. Inception of modern electronic technologies such as minimally invasive surgery equipment, and robotic & power assisted systems are primarily driving the surgical equipment market.
    Jul 2014 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
  • ...
    Mobile health (mHealth) is a branch of electronic health (eHealth) that delivers revolutionized healthcare service in which communication devices are used for the remote monitoring of patients suffering from acute and chronic diseases. mHealth majorly involves the use of mobile and wireless technologies, which are deployed in monitoring and treatment of several diseases.
    May 2015 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
ON DEMAND REPORTS
  • ...
    Peripheral vascular disease is a blood circulation disorder, which reduces the flow of blood through blood vessels located outside the heart and brain. When these vessels do not supply sufficient blood, it results in the abnormal functioning of organs. Peripheral vascular device are used to measure blood flow from arteries and veins. Peripheral vascular device would be in demand due to its minimally invasive endovascular treatment, rising prevalence of diseases such as diabetes & obesity and growing aging population.
    Sep 2015 | View Details >>
  • ...
    Dialysis is the process of removing excess water and waste from the blood by artificial means, primarily in cases of renal failure. It is also used for patients with acute disturbances in kidney function or chronic kidney disease. The aim of this report is to provide an insight of the market scenario of dialysis. This report discusses the products and services available to provide an understanding of current industrial status.
    Sep 2015 | View Details >>
  • ...
    Insulin regulates fat and carbohydrate metabolism in the body. It is a peptide hormone, which is secreted in the pancreas by beta cells of the islets of Langerhans and it helps to regulate the glucose metabolism. It causes skeletal muscle cells and fat tissues to absorb glucose from the blood. The global human insulin market is expected to grow at healthy CAGR during the forecast period due to high prevalence of diabetes, worldwide. In-depth analysis of the global human insulin market focuses on various aspects of the market such as market trends, market drivers, restraints and opportunities.
    Sep 2015 | View Details >>
  • ...
    Illegal drug is non-prescribed type of drug taken for non-medicinal reasons that affects physical and mental health of addicts. According to National Survey on Drug Use and Health, 19.9 million Americans use illegal drugs in a month. There were more than 208 million people consuming illegal drugs worldwide. Change in life style attracts younger people to consume illicit drugs, which is a major driver for this market. There are 253,000 death occurred due to consumption of illicit drugs out of which 1.3% are of the age between 15-35 years in US. Increase in variety of drug consumption ceases the flexibility of drug testing devices.
    Sep 2015 | View Details >>